The CDM device wirelessly transmits patient data and combines event recording which aids physicians to continuously monitor patient cardiac events remotely.
The CDM device offers diagnostic evaluation of patients with symptoms of cardiac arrhythmia and its recorded cardiac activity is viewed by a licensed physician.
IntriCon president and CEO Mark Gorder said they are excited to offer a device that will not only improve patient quality of life, but also reduce treatment costs by providing the ability to identify asymptomatic cardiac events remotely.
